69
Quando procedere all’ablazione della tachicardia ventricolare rinunciando al defibrillatore Leonardo Calo’ Direttore U.O.C. Cardiologia Policlinico Casilino -Roma

Quando procedere all’ablazione della tachicardia ... · Quando procedere all’ablazione della tachicardia ventricolare rinunciando al defibrillatore Leonardo Calo’ Direttore

Embed Size (px)

Citation preview

Quando procedere all’ablazione della tachicardia ventricolare

rinunciando al defibrillatore

Leonardo Calo’

Direttore U.O.C. Cardiologia

Policlinico Casilino -Roma

DISCLOSURE INFORMATION

No conflict of interest

In 11 pts (group B; 35%), electroanatomic voltage mapping was normal.

Low-voltage areas in pts from group A corresponded to echocardiographic/angiographic RV wall motion abnormalities and were significantly associated with myocyte loss and fibrofatty replacement at biopsy (P < 0.0001) and familial ARVC/D (P < 0.0001).

“Border-zone”

I

Abld

I

Abld

I

Abld

Variable diastolic potentials at the site of successful ablation

Circulation 2006;114:32-39

An example of CMR in a 64-year-old male patient with an inferior MI (white arrows), preserved LV systolic function (LVEF, 61%), and normal LV systolic volume index. The MI of this pt was characterized by a substantial peri-infarct zone (yellow region) with a %MDE periphery measuring 27%. The patient died 11 months after undergoing the CMR examination.

TV1

TV2, 3

TV4, 5, 6

Ablazione del substrato

aritmogeno di TV, FE 15%, NYHA

III, ICD

Con isoproterenolo

22-years old male - No structural heart disease - Palpitations

* * *

TV IDIOPATICA DEL VENTRICOLO SN

A

B

* *

AO Adx

Vdx TE

Vsn

TV IDIOPATICA DEL TRATTO DI EFFLUSSO SN

Cuspide coronarica sn - Cuspide coronarica dx-

Setto interventricolare

Origin of outflow tract ventricular arrhythmia

Yamada, JACC 2008; 52(2), 139–147

About 70% of outflow tract VA are from RVOT, inferior to the PV

Catheter Ablation - Outcome

Aliot EM,et al.: EHRA/HRS Expert Consensus on Catheter ablation of VA. Europace 2009, 11:771–817

• Acute success rate typically > 90%

• Recurrences occur in about 5% of cases

• Complications during ablation of idiopathic VTs are rare

– mainly related to vascular access

– tamponade or perforation occur in < 1% of the cases • Long-term follow-ups and larger sample sizes are still missing

Tachycardia-Related Cardiomyopathy

• TCM is caused by very frequent runs of VT as well as PVCs

• The threshold of ectopy needed to result in TCM has been evaluated by many authors:

– Yarlagadda et al. PVC > 17,000 daily

– Takemoto et al. PVC > 20% daily

– Baman et al. PVC > 24% daily

– Hasdemir et al. PVC > 16% daily

– Niwano et al. PVC > 31,268 daily

• Thus, patients likely need to have > 10,000 PVCs daily over a substantial period (≈4 years) to cause TCM

• TCM is uncommon and occurred in 5-6% of patients

Eric N. Prystowsky et al. J Am Coll Cardiol 2012;59:1733–44

PVC-induced cardiomyopathy: mechanisms

Niwano et al Heart 2009

Cut point 20000/24h

PVCs number

Case 1

Ablation site

Pt 2 E.F. Male - 44 yrs

baseline Post RFA - 6 months

Case 2

Medical history

M.A. 59 years old female

Hypercholesterolemia; no other risk factors

Highly symptomatic for palpitations since several months

NYHA class II

Echo: Mitral valve prolapse with mild regurgitation; EF 46%; LVED 56 mm

On therapy with betablockers: persistence of symptoms

Holter: sinus rhythm; 34000 PVCs (two morphologies; one highly predominant); couplets; frequent runs of NSVT

Cardiac MRI LVEF 45%

No evidence of right vetricular delayed enhancement

Abl u

Abl

Endocardial signals at successful site

RF ablation

Parameters: 25 to 30 W and 43°; thermocool

Final ECG

Follow-up Bisoprolol was interrupted at 30 days follow-up

At 45 days follow up the patient is asymptomatic

24 hours Holter: normal sinus rhythm; 48 polymorfic PVCs

Echo: Slitght improvement of EF from 46% to 50% at 2 months

Case 3

Athlete 35 y.o. male caucasian with 15000 polymorphic PVC, isolated, 228 couplets, 15 NSVT 4 beats

Athlete 35 y.o. male caucasian with 15000 polymorphic PVC, isolated, 228 couplets, 15 NSVT 4 beats

MRI late enhancement inferior basal wall

Athlete 35 y.o. male caucasian with 15000 polymorphic PVC, isolated, 228 couplets, 15 NSVT 4 beats

Case 4

34 y.o. male caucasian with repetitive monomorphic NSVT No family history of heart disease

Symptomatic for palpitations, no syncope

34 y.o. male caucasian with repetitive monomorphic NSVT (GALLAVARDIN)

MRI: absence of cardiomyopathy

Holter monitoring:

27000 PVC, absence during sleep.

NSVT during Holter monitoring.

MRI absence of heart disease

EPS no inducibility of arrhythmias

No low voltage areas during electroanatomical mapping

Electrophysiological study:

mapping of right ventricular outflow tract (RVOT), inducibility of arrhythmias, RF ablation

Case 5

MRI absence of heart disease

EPS no inducibility of arrhythmias

No low voltage areas during

electroanatomical mapping